Contemporary diagnosis and management of severe tricuspid regurgitation.
replacement
transcatheter valve repair
tricuspid regurgitation
Journal
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
revised:
23
04
2022
received:
10
06
2021
accepted:
09
07
2022
pubmed:
11
9
2022
medline:
13
10
2022
entrez:
10
9
2022
Statut:
ppublish
Résumé
Many novel percutaneous interventions are being developed for application in the tricuspid valve position. At the present time in the United States, there are no commercially available transcathter devices for this application. This article reviews the growing evidence for diagnosing, imaging, and treating severe tricuspid regurgitation as well as the surgical and transcatheter options that are under current development and in various stages of clinical trials.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
646-661Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
Zack CJ, Fender EA, Chandrashekar P, et al. National trends and outcomes in isolated tricuspid valve surgery. J Am Coll Cardiol. 2017;70(24):2953-2960.
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e72-e227.
Fender EA, Zack CJ, Nishimura RA. Isolated tricuspid regurgitation: outcomes and therapeutic interventions. Heart. 2018;104(10):798-806.
Ong K, Yu G, Jue J. Prevalence and spectrum of conditions associated with severe tricuspid regurgitation. Echocardiography. 2014;31(5):558-562.
Behm CZ, Nath J, Foster E. Clinical correlates and mortality of hemodynamically significant tricuspid regurgitation. J Heart Valve Dis. 2004;13(5):784-789.
Mutlak D, Lessick J, Reisner SA, Aronson D, Dabbah S, Agmon Y. Echocardiography-based spectrum of severe tricuspid regurgitation: the frequency of apparently idiopathic tricuspid regurgitation. J Am Soc Echocardiogr. 2007;20(4):405-408.
Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol. 2004;43(3):405-409.
Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(22):e57-e185.
Antunes MJ, Rodríguez-Palomares J, Prendergast B, et al. Management of tricuspid valve regurgitation: position statement of the European Society of Cardiology Working Groups of Cardiovascular Surgery and Valvular Heart Disease. Eur J Cardiothorac Surg. 2017;52(6):1022-1030.
Bernal JM, Pontón A, Diaz B, et al. Surgery for rheumatic tricuspid valve disease: a 30-year experience. J Thorac Cardiovasc Surg. 2008;136(2):476-481.
Goswami KC, Rao MB, Dev V, Shrivastava S. Juvenile tricuspid stenosis and rheumatic tricuspid valve disease: an echocardiographic study. Int J Cardiol. 1999;72(1):83-86.
Fox DJ, Khattar RS. Carcinoid heart disease: presentation, diagnosis, and management. Heart. 2004;90(10):1224-1228.
Bhattacharyya S, Davar J, Dreyfus G, Caplin ME. Carcinoid heart disease. Circulation. 2007;116(24):2860-2865.
Lin G, Nishimura RA, Connolly HM, Dearani JA, Sundt TM, Hayes DL. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads. J Am Coll Cardiol. 2005;45(10):1672-1675.
Al-Mohaissen MA, Chan KL. Prevalence and mechanism of tricuspid regurgitation following implantation of endocardial leads for pacemaker or cardioverter-defibrillator. J Am Soc Echocardiogr. 2012;25(3):245-252.
Höke U, Auger D, Thijssen J, et al. Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up. Heart. 2014;100(12):960-968.
Delling FN, Hassan ZK, Piatkowski G, et al. Tricuspid regurgitation and mortality in patients with transvenous permanent pacemaker leads. Am J Cardiol. 2016;117(6):988-992.
Dahou A, Levin D, Reisman M, Hahn RT. Anatomy and physiology of the tricuspid valve. JACC Cardiovasc Imaging. 2019;12(3):458-468.
Ton-Nu TT, Levine RA, Handschumacher MD, et al. Geometric determinants of functional tricuspid regurgitation: insights from 3-dimensional echocardiography. Circulation. 2006;114(2):143-149.
Hung J, Koelling T, Semigran MJ, Dec GW, Levine RA, Di Salvo TG. Usefulness of echocardiographic determined tricuspid regurgitation in predicting event-free survival in severe heart failure secondary to idiopathic-dilated cardiomyopathy or to ischemic cardiomyopathy. Am J Cardiol. 1998;82(10):1301-1303.
Kazum SS, Sagie A, Shochat T, et al. Prevalence, echocardiographic correlations, and clinical outcome of tricuspid regurgitation in patients with significant left ventricular dysfunction. Am J Med. 2019;132(1):81-87.
Topilsky Y, Maltais S, Medina Inojosa J, et al. Burden of tricuspid regurgitation in patients diagnosed in the community setting. JACC Cardiovasc Imaging. 2019;12(3):433-442.
Benfari G, Antoine C, Miller WL, et al. Excess mortality associated with functional tricuspid regurgitation complicating heart failure with reduced ejection fraction. Circulation. 2019;140(3):196-206.
Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017;30(4):303-371.
Badano LP, Agricola E, Perez de Isla L, Gianfagna P, Zamorano JL. Evaluation of the tricuspid valve morphology and function by transthoracic real-time three-dimensional echocardiography. Eur J Echocardiogr. 2009;10(4):477-484.
Hahn RT, Weckbach LT, Noack T, et al. Proposal for a standard echocardiographic tricuspid valve nomenclature. JACC Cardiovasc Imaging. 2021;14(7):1299-1305.
Rodes-Cabau J, Taramasso M, O'Gara PT. Diagnosis and treatment of tricuspid valve disease: current and future perspectives. Lancet. 2016;388(10058):2431-2442.
Winkel MG, Brugger N, Khalique OK, et al. Imaging and patient selection for transcatheter tricuspid valve interventions. Front Cardiovasc Med. 2020;7:60.
Agricola E, Asmarats L, Maisano F, et al. Imaging for tricuspid valve repair and replacement. JACC Cardiovasc Imaging. 2021;14(1):61-111.
Fortuni F, Hirasawa K, Marques AI, et al. Computed tomography-derived transesophageal echocardiographic views: step forward for procedural planning of transcatheter tricuspid valve annuloplasty. Circ Cardiovasc Imaging. 2021;14(1):e011107.
Hahn RT, Zamorano JL. The need for a new tricuspid regurgitation grading scheme. Eur Heart J Cardiovasc Imaging. 2017;18(12):1342-1343.
Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739-2791.
Sugeng L, Weinert L, Lang RM. Real-time 3-dimensional color Doppler flow of mitral and tricuspid regurgitation: feasibility and initial quantitative comparison with 2-dimensional methods. J Am Soc Echocardiogr. 2007;20(9):1050-1057.
Rodriguez L, Anconina J, Flachskampf FA, Weyman AE, Levine RA, Thomas JD. Impact of finite orifice size on proximal flow convergence. Implications for Doppler quantification of valvular regurgitation. Circ Res. 1992;70(5):923-930.
de Agustin JA, Viliani D, Vieira C, et al. Proximal isovelocity surface area by single-beat three-dimensional color Doppler echocardiography applied for tricuspid regurgitation quantification. J Am Soc Echocardiogr. 2013;26(9):1063-1072.
Öztürk C, Schueler R, Weber M, Nickenig G, Hammerstingl C. Comparison of different imaging modalities for the quantification of tricuspid valve geometry and regurgitation: a retrospective, single-center study. Health Sci Rep. 2020;3(2):e159.
Topilsky Y, Nkomo VT, Vatury O, et al. Clinical outcome of isolated tricuspid regurgitation. JACC Cardiovasc Imaging. 2014;7(12):1185-1194.
Hahn RT, Meduri CU, Davidson CJ, et al. Early feasibility study of a transcatheter tricuspid valve annuloplasty: SCOUT trial 30-day results. J Am Coll Cardiol. 2017;69(14):1795-1806.
Taramasso M, Hahn RT, Alessandrini H, et al. The international multicenter TriValve registry: which patients are undergoing transcatheter tricuspid repair. JACC Cardiovasc Interv. 2017;10(19):1982-1990.
Hahn RT, Abraham T, Adams MS, et al. Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr. 2013;26(9):921-964.
Hahn RT. State-of-the-art review of echocardiographic imaging in the evaluation and treatment of functional tricuspid regurgitation. Circ Cardiovasc Imaging. 2016;9:12.
Wang TKM, Harb SC, Miyasaka RL, et al. Live three-dimensional multiplanar reconstruction imaging guidance for concomitant mitral and tricuspid valve repairs using the MitraClip. CASE (Phila). 2020;4(3):119-126.
Fam NP, Samargandy S, Gandhi S, Eckstein J. Intracardiac echocardiography for guidance of transcatheter tricuspid edge-to-edge repair. EuroIntervention. 2018;14(9):e1004-e1005.
Eleid MF, Alkhouli M, Thaden JJ, et al. Utility of intracardiac echocardiography in the early experience of transcatheter edge to edge tricuspid valve repair. Circ Cardiovasc Interv. 2021;14:e011118.
Berti S DAA, Pastormelo L, Trianni G, Mariani M. Tricuspid cardioband: in-valve positioning of intracardiac echocardiography probe. JACC Cardiovasc Interv. 2022;15(9):992-995.
Kichou B HN, Kichou L, Himeur Y, Ait Said M, Mazeghrane A. Outcome of patients with severe secondary tricuspid regurgitation treated first with diuretics. Arch Cardiovasc Dis Suppl. 2019;11(1):75.
Braunwald NS, Ross J, Jr., Morrow AG. Conservative management of tricuspid regurgitation in patients undergoing mitral valve replacement. Circulation. 1967;35(suppl 4):I63-I69.
Song H, Kim MJ, Chung CH, et al. Factors associated with development of late significant tricuspid regurgitation after successful left-sided valve surgery. Heart. 2009;95(11):931-936.
Sagie A, Schwammenthal E, Newell JB, et al. Significant tricuspid regurgitation is a marker for adverse outcome in patients undergoing percutaneous balloon mitral valvuloplasty. J Am Coll Cardiol. 1994;24(3):696-702.
Matsunaga A, Duran CM. Progression of tricuspid regurgitation after repaired functional ischemic mitral regurgitation. Circulation. 2005;112(suppl 9):I453-I457.
Kusajima K, Fujita T, Hata H, Shimahara Y, Miura S, Kobayashi J. Long-term echocardiographic follow-up of untreated 2+ functional tricuspid regurgitation in patients undergoing mitral valve surgery. Interact Cardiovasc Thorac Surg. 2016;23(1):96-103.
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561-632.
Hamandi M, Smith RL, Ryan WH, et al. Outcomes of isolated tricuspid valve surgery have improved in the modern era. Ann Thorac Surg. 2019;108(1):11-15.
Kilic A, Saha-Chaudhuri P, Rankin JS, Conte JV. Trends and outcomes of tricuspid valve surgery in North America: an analysis of more than 50,000 patients from the Society of Thoracic Surgeons database. Ann Thorac Surg. 2013;96(5):1546-1552.
Sales VL, McCarthy PM. Durability of functional tricuspid valve repair. Semin Thorac Cardiovasc Surg. 2010;22(1):97-103.
Guenther T, Mazzitelli D, Noebauer C, et al. Tricuspid valve repair: is ring annuloplasty superior. Eur J Cardiothorac Surg. 2013;43(1):58-65.
Ratschiller T, Guenther T, Guenzinger R, et al. Early experiences with a new three-dimensional annuloplasty ring for the treatment of functional tricuspid regurgitation. Ann Thorac Surg. 2014;98(6):2039-2044.
Perlman G, Praz F, Puri R, et al. Transcatheter tricuspid valve repair with a new transcatheter coaptation system for the treatment of severe tricuspid regurgitation: 1-year clinical and echocardiographic results. JACC Cardiovasc Interv. 2017;10(19):1994-2003.
Orban M, Rommel KP, Ho EC, et al. Transcatheter edge-to-edge tricuspid repair for severe tricuspid regurgitation reduces hospitalizations for heart failure. JACC Heart Fail. 2020;8(4):265-276.
Taramasso M, Alessandrini H, Latib A, et al. Outcomes after current transcatheter tricuspid valve intervention: mid-term results from the international TriValve registry. JACC Cardiovasc Interv. 2019;12(2):155-165.
Braun D, Orban M, Orban M, et al. Transcatheter edge-to-edge repair for severe tricuspid regurgitation using the triple-orifice technique versus the bicuspidalization technique. JACC Cardiovasc Interv. 2018;11(17):1790-1792.
Lurz P, Stephan von Bardeleben R, Weber M, et al. Transcatheter edge-to-edge repair for treatment of tricuspid regurgitation. J Am Coll Cardiol. 2021;77(3):229-239.
Kodali S, Hahn RT, Eleid MF, et al. Feasibility study of the transcatheter valve repair system for severe tricuspid regurgitation. J Am Coll Cardiol. 2021;77(4):345-356.
Puri R, Rodes-Cabau J. The FORMA repair system. Interv Cardiol Clin. 2018;7(1):47-55.
Asmarats L, Perlman G, Praz F, et al. Long-term outcomes of the FORMA transcatheter tricuspid valve repair system for the treatment of severe tricuspid regurgitation: insights from the first-in-human experience. JACC Cardiovasc Interv. 2019;12(15):1438-1447.
Planer D, Beeri R, Danenberg HD. First-in-human transcatheter tricuspid valve repair: 30-day follow-up experience with the mistral device. JACC Cardiovasc Interv. 2020;13(18):2091-2096.
Park YH, Chon MK, Lederman RJ, et al. Mitral loop cerclage annuloplasty for secondary mitral regurgitation: first human results. JACC Cardiovasc Interv. 2017;10(6):597-610.
Min-Ku C, S.-M. J, Soo Yong L, et al. TCT-18 novel concept of catheter-based treatment for tricuspid regurgitation (Cerclage-TR block): a preliminary animal experiment in a swine model. J Am Coll Cardiol. 2018;72(13 suppl):B8.
O'Connor S. Temporary implantation of the CroiValve DUO coaptation valve in patients with massive and torrential tricuspid regurgitation in TCT. 2021.
Nickenig G, Weber M, Schueler R, et al. 6-month outcomes of tricuspid valve reconstruction for patients with severe tricuspid regurgitation. J Am Coll Cardiol. 2019;73(15):1905-1915.
Nickenig G, Weber M, Schüler R, et al. Tricuspid valve repair with the Cardioband system: two-year outcomes of the multicentre, prospective TRI-REPAIR study. EuroIntervention. 2021;16(15):e1264-e1271.
Rogers JH, Boyd WD, Bolling SF. Tricuspid annuloplasty with the Millipede ring. Prog Cardiovasc Dis. 2019;62(6):486-487.
Rogers T, Ratnayaka K, Sonmez M, et al. Transatrial intrapericardial tricuspid annuloplasty. JACC Cardiovasc Interv. 2015;8(3):483-491.
Kay JH, Maselli-Campagna G, Tsuji KK. Surgical treatment of tricuspid insufficiency. Ann Surg. 1965;162:53-58.
Besler C, Meduri CU, Lurz P. Transcatheter treatment of functional tricuspid regurgitation using the trialign device. Interv Cardiol. 2018;13(1):8-13.
Hetzer R, Javier M, Delmo Walter EM. The double-orifice valve technique to treat tricuspid valve incompetence. J Heart Valve Dis. 2016;25(1):66-71.
Khan JM, Rogers T, Schenke WH, et al. Transcatheter pledget-assisted suture tricuspid annuloplasty (PASTA) to create a double-orifice valve. Catheter Cardiovasc Interv. 2018;92(3):E175-E184.
PCR E. Willard Hennemann P, ed. STTAR: The Study of Transcatheter Tricuspid Annular Repair, 2020. https://media.pcronline.com/diapos/PCReCourse2020/212-20200625_1758_Hotline_and_Innovation_Channel_Hennemann_Willard_0000_(483)/Hennemann_Willard_20200625_1750_Hotline_and_Innovation_-_Channel_3.pdf
Kerner A. DaVingi™ tricuspid repair system technology and clinical updates in TCT. 2018.
Latib A, Agricola E, Pozzoli A, et al. First-in-man implantation of a tricuspid annular remodeling device for functional tricuspid regurgitation. JACC Cardiovasc Interv. 2015;8(13):e211-e214.
Navia JL, Kapadia S, Elgharably H, et al. First-in-human implantations of the NaviGate bioprosthesis in a severely dilated tricuspid annulus and in a failed tricuspid annuloplasty ring. Circ Cardiovasc Interv. 2017;10:12.
Navia JL, Kapadia S, Elgharably H, et al. Transcatheter tricuspid valve implantation of NaviGate bioprosthesis in a preclinical model. JACC Basic Transl Sci. 2018;3(1):67-79.
Hahn R. NAVIGATE transcatheter tricuspid valve replacement…early findings-technology and clinical updates in TCT. 2018.
Hahn RT, George I, Kodali SK, et al. Early single-site experience with transcatheter tricuspid valve replacement. JACC Cardiovasc Imaging. 2019;12(3):416-429.
Vaturi M, Vaknin-Assa H, Shapira Y, et al. First-in-human percutaneous transcatheter tricuspid valve replacement with a novel valve. JACC Case Rep. 2021;3(10):1281-1286.
Lu FL, Ma Y, An Z, et al. First-in-man experience of transcatheter tricuspid valve replacement with LuX-Valve in high-risk tricuspid regurgitation patients. JACC Cardiovasc Interv. 2020;13(13):1614-1616.
Sun Z, Li H, Zhang Z, et al. Twelve-month outcomes of the LuX-Valve for transcatheter treatment of severe tricuspid regurgitation. EuroIntervention. 2021;17(10):818-826.
TriCares. TRiCares announces successful first in human implantations of minimally invasive topaz tricuspid heart valve replacement system. 2021. https://www.tricares.com/assets/2021_Press_EN.pdf
Fam NP, von Bardeleben RS, Hensey M, et al. Transfemoral transcatheter tricuspid valve replacement with the EVOQUE system: a multicenter, observational, first-in-human experience. JACC Cardiovasc Interv. 2021;14(5):501-511.
Kodali S. TRISCEND: six-month outcomes of transfemoral tricuspid valve replacement in patients with tricuspid regurgitation in TCT. 2021.
Bapat V. The INTREPID valve for severe tricuspid regurgitation: case experience in CRT. 2020.
Laule M, Stangl V, Sanad W, Lembcke A, Baumann G, Stangl K. Percutaneous transfemoral management of severe secondary tricuspid regurgitation with Edwards Sapien XT bioprosthesis: first-in-man experience. J Am Coll Cardiol. 2013;61(18):1929-1931.
Dreger H, Mattig I, Hewing B, et al. Treatment of severe TRIcuspid regurgitation in patients with advanced heart failure with CAval vein implantation of the Edwards Sapien XT VALve (TRICAVAL): a randomised controlled trial. EuroIntervention. 2020;15(17):1506-1513.
Lauten A, Ferrari M, Hekmat K, et al. Heterotopic transcatheter tricuspid valve implantation: first-in-man application of a novel approach to tricuspid regurgitation. Eur Heart J. 2011;32(10):1207-1213.
Toggweiler S, De Boeck B, Brinkert M, et al. First-in-man implantation of the Tricento transcatheter heart valve for the treatment of severe tricuspid regurgitation. EuroIntervention. 2018;14(7):758-761.